Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment

Background: Fatigue is a common complaint in patients with idiopathic pulmonary fibrosis (IPF) and has been reported in a considerable percentage of patients. Fatigue is also a registered side effect of pirfenidone, one of two approved antifibrotic drugs. The Fatigue Assessment Scale (FAS) was devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kølner-Augustson, Line, Prior, Thomas Skovhus, Skivild, Vibeke, Aalestrup, Anette, Bendstrup, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717873/
https://www.ncbi.nlm.nih.gov/pubmed/33312458
http://dx.doi.org/10.1080/20018525.2020.1853658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717873/
https://www.ncbi.nlm.nih.gov/pubmed/33312458
http://dx.doi.org/10.1080/20018525.2020.1853658

Ejemplares similares